A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer
about
The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy.Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer.
P2860
A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@ast
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@en
type
label
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@ast
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@en
prefLabel
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@ast
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@en
P2093
P2860
P356
P1476
A phase II study of nab-paclit ...... ced non-small-cell lung cancer
@en
P2093
Akane Horiba
Daizo Kaito
Shinya Hayashi
Takayoshi Iida
Tatsuo Kato
Toshitaka Suzuki
Tsutomu Yoshida
Yasuhi Ohno
Yohei Futamura
P2860
P356
10.1093/JRR/RRV062
P577
2015-10-05T00:00:00Z